Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The study was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments and International Council for Harmonisation (ICH) Good Clinical Practice guidelines
PMID: 42269582 J Clin Invest 2025 Aug 26:e186652
You can link users to your Lab Tests page
Because Melanotan 2 is sold strictly for laboratory research purposes, there is no approved dosage for human use
Key findings from the 2026 study include: Within six months of starting GLP-1 therapy, the rate of hypotensive events rose from 8.7% to 10.2%
The mechanisms are well established: Reduced cardiac output
US$ 23.88
US$ 29.27
US$ 26.98
US$ 28.79
US$ 23.77
